APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging

Dementia and Geriatric Cognitive Disorders

Volumn 15, Issue 1, 2003, Pages 1-5

  Klages, Jennifer D ^a   Fisk, John D ^a,b   Rockwood, Kenneth ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Alzheimer's disease; Apolipoproteins; Cognitive disorders; Epidemiology; Neurogenetics

Indexed keywords

APOLIPOPROTEIN E4;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; COGNITION; CONTROLLED STUDY; DEMENTIA; FEMALE; FOLLOW UP; GENOTYPE; HEALTH SURVEY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEMORY; NEUROPSYCHOLOGICAL TEST; PREDICTION; PRIORITY JOURNAL; RATING SCALE; RISK ASSESSMENT; TASK PERFORMANCE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CANADA; COGNITION DISORDERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LONGITUDINAL STUDIES; MALE; MEMORY; NEUROPSYCHOLOGICAL TESTS; PROTEIN ISOFORMS; RISK ASSESSMENT; TASK PERFORMANCE AND ANALYSIS;

EID: 0037211404     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066670     Document Type: Article

References (30)

1. Rebeck GW, Hyman BT: Apolipoprotein E and Alzheimer disease; in Terry RD, Katzman R, Bick KL, Sisodia SS (eds): Alzheimer Disease, Ed 2. Philadelphia, Lippincott Williams & Wilkins, 1999, pp 339-346.
2. APOE and Alzheimer Disease Meta Analysis Consortium: Effects of age, sex and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. JAMA 1997;278:1349-1356.
3. Graham JE, Rockwood K, Beattie BL, Eastwood R, Gauthier S, Tuokko HJ, McDowell I: Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997;349:1793-1796.
4. Peterson RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 1999;56:303-308.
5. Ritchie K, Touchon J: Mild cognitive impairment: Conceptual basis and current nosological status. Lancet 2000;355:225-228.
6. Tierney MC, Szalai JP, Snow WG, Fisher RH, Nores A, Nadon G, Dunn E, St George-Hyslop PH: Prediction of probable Alzheimer's disease in memory-impaired patients: A prospective longitudinal study. Neurology 1996;46:661-665.
7. Elias MF, Beiser A, Wolf PA, Au R, White RF, D'Agostino RB: The preclinical phase of Alzheimer disease: A 22-year prospective study of the Framingham Cohort. Arch Neurol 2000;57:808-813.
8. Small BJ, Fratiglioni L, Viitanen M, Winblad B, Bäckman L: The course of cognitive impairment in preclinical Alzheimer disease: Three-and 6-year follow-up of a population-based sample. Arch Neurol 2000;57:839-844.
9. Reed T, Carmelli D, Swan GE, Breitner JC, Welsh KA, Jarvik GP, Beeb S, Auwerx J: Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E ε4 allele. Arch Neurol 1994;51:1189-1192.
10. Staehelin HB, Perrig-Chiello P, Mitrache C, Miserez AR, Perrig WJ: Apolipoprotein E genotypes and cognitive functions in healthy elderly persons. Acta Neurol Scand 1999;100:53-60.
11. Bondi MW, Salmon DP, Monsch AU, Galasko D, Butters N, Klauber MR, Thal L, Saitoh T: Episodic memory changes are associated with the APOE-ε4 allele in nondemented older adults. Neurology 1995;45:2203-2206.
12. Smith GE, Bohac DL, Waring SC, Kokmen E, Tanglos EG, Ivnik RJ, Petersen RC: Apolipoprotein E genotype influences cognitive 'genotype' in patients with Alzheimer's disease but not in healthy control subjects. Neurology 1998;50:355-362.
13. Tierney MC, Szalai JP, Snow WG, Fisher RH, Tsuda T, Chi H, McLachlan, St George-Hyslop PH: A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory impairment. Neurology 1996;46:149-154.
14. Canadian Study of Health and Aging Working Group: Canadian Study of Health and Aging: Study methods and prevalence of dementia. Can Med Assoc J 1994;150:899-913.
15. Canadian Study of Health and Aging Working Group: The incidence of dementia in Canada. Neurology 2000;55:66-73.
16. McDowell I, Aylesworth R, Stewart M, Hill G, Lindsay J: Study sampling in the Canadian Study of Health and Aging. Int Psychogeriatr 2001;13:19-28.
17. Teng EL, Chui HC: The Modified Mini-Mental State (3MS) Examination. J Clin Psychiatry 1987;48:314-318.
18. McLeod DA, Arnott B, Gaudreault N, Boudreau S, Sevigny P: A comparison of two methods for routine, accurate determination of apolipoprotein E genotypes. Alzheimer's Rep 1998;1:211-215.
19. Yee IM, Feldman H, Sadovnick D: The effect of apolipoprotein E genotypes in Alzheimer's disease: Data from the Canadian Study of Health and Aging. Neurobiol Aging 2000;21(1S):S36-S37.
20. Graham JE, Rockwood K, Beattie BL, McDowell I, Eastwood R, Gauthier S: Standardization of the diagnosis of dementia in the Canadian Study of Health and Aging. Neuroepidemiology 1996;15:246-256.
21. Tuokko H, Kristjansson E, Miller J: Neuropsychological detection of dementia: An overview of the neuropsychological component of the Canadian Study of Health and Aging. J Clin Exp Neuropsychol 1995;17:352-373.
22. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Ed 3, Revised. Washington, American Psychiatric Association, 1987.
23. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
24. Tuokko H, Crockett D: Cued recall and memory disorders in dementia. J Clin Exp Neuropsychol 1989;11:278-294.
25. Petersen RC, Smith G, Kokmen E, Ivnik RJ, Tangalos EG: Memory function in normal aging. Neurology 1992;42:396-401.
26. Tuokko H, Vernon-Wilkinson R, Weir J, Beattie L: Cued recall and early identification of dementia. J Clin Exp Neuropsychol 1991;13:871-879.
27. Collie A, Maruff P, Shafiq-Antonacci R, Smith M, Hallup M, Schofield PR, Masters CL, Currie J: Memory decline in healthy older people: Implications for identifying mild cognitive impairment. Neurology 2001;56:1533-1538.
28. Petersen RC, Stevens JC, Ganguli M, Tanglos EG, Cummings JL, DeKosky ST: Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review). Neurology 2001;56:1133-1142.
29. Fisk JD, Sadovnik AD, Cohen CA, Gauthier S, Dossetor J, Eberhart A, LeDuc L: Ethical guidelines of the Alzheimer Society of Canada. Can J Neurol Sci 1998;25:242-248.
30. AGS Ethics Committee: Genetic testing for late-onset Alzheimer's disease. J Am Geriatr Soc 2001;49:225-226.